Drug
Who makes oxybutynin chloride?
36 companies list oxybutynin chloride as a human prescription drug. Forms: solution; syrup; tablet; tablet, extended release. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing oxybutynin chloride
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| International Medication Systems, Ltd.United States | tablet; tablet, extended release | ANDAANDA206121, ANDA207138, ANDA209025 | 11 | 3 |
| Aphena Pharma Solutions - Tennessee, LLC | tablet; tablet, extended release | ANDAANDA074625, ANDA075079, ANDA078503 | 8 | 0 |
| Bryant Ranch PrepackUnited States | tablet; tablet, extended release | ANDAANDA071655, ANDA206121, ANDA207138 | 7 | 1 |
| PD-Rx Pharmaceuticals Inc.United States | tablet; tablet, extended release | ANDAANDA078503, ANDA206121, ANDA207138 | 7 | 1 |
| Rising Pharma Holdings, Inc.United States | tablet; tablet, extended release | ANDAANDA206121, ANDA209025 | 7 | 1 |
| Lannett Company, LLCUnited States | syrup; tablet, extended release | ANDAANDA074520, ANDA078503 | 4 | 1 |
| AvKARE | tablet; tablet, extended release | ANDAANDA078503, ANDA208165 | 4 | 0 |
| Chartwell RX, LLC. | solution; tablet, extended release | ANDAANDA075039, ANDA078503 | 4 | 0 |
| Pharma Packaging Solutions, LLC dba Tjoapack, LLCUnited States | tablet; tablet, extended release | ANDAANDA078503, ANDA208165 | 3 | 5 |
| Strides Pharma Science LimitedIndia | tablet | ANDAANDA075079, ANDA208165 | 3 | 5 |
| ACCORD HEALTHCARE LIMITEDUnited Kingdom | tablet, extended release | ANDAANDA207138 | 3 | 2 |
| Ajanta Pharma LimitedIndia | tablet, extended release | ANDAANDA211655 | 3 | 2 |
| Amneal Ireland LimitedIreland | tablet, extended release | ANDAANDA204010 | 3 | 1 |
| Coupler LLCUnited States | tablet; tablet, extended release | ANDAANDA208165, ANDA211655 | 3 | 1 |
| Direct RxUnited States | tablet; tablet, extended release | ANDAANDA071655, ANDA207138 | 3 | 1 |
| Proficient Rx LPUnited States | tablet; tablet, extended release | ANDAANDA071655, ANDA206121, ANDA207138 | 3 | 1 |
| Advagen Pharma Limited | tablet, extended release | ANDAANDA214415 | 3 | 0 |
| AvPAK | tablet, extended release | ANDAANDA078503 | 3 | 0 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.United States | tablet | ANDAANDA208165, ANDA211682 | 2 | 1 |
| Northwind Health Company, LLCUnited States | tablet | ANDAANDA209335, ANDA209823 | 2 | 1 |
| MAJOR Pharmaceuticals Inc. | tablet; tablet, extended release | ANDAANDA204010, ANDA209823 | 2 | 0 |
| TruPharma LLC. | tablet | ANDAANDA210125 | 2 | 0 |
| Cardinal Health 418, Inc.United States | tablet | ANDAANDA209823 | 1 | 34 |
| KVK-TECH, INC.United States | tablet | ANDAANDA209335 | 1 | 2 |
| ANI Pharmaceuticals, Inc.United States | tablet | ANDAANDA209823 | 1 | 1 |
| Golden State Medical Supply Inc.United States | tablet | ANDAANDA209823 | 1 | 1 |
| Leading Pharma, LLCUnited States | tablet | ANDAANDA212798 | 1 | 1 |
| NCS HealthCare of KY, LLC dba Vangard LabsUnited States | tablet | ANDAANDA212798 | 1 | 1 |
| NuCare Pharmaceuticals,Inc.United States | tablet | ANDAANDA209823 | 1 | 1 |
| Preferred Pharmaceuticals Inc.United States | tablet | ANDAANDA209335 | 1 | 1 |
| RedPharm DrugUnited States | tablet | ANDAANDA212798 | 1 | 1 |
| RemedyRepack, IncUnited States | tablet | ANDAANDA209335 | 1 | 1 |
| South Atlantic Corporation LLCUnited States | syrup | ANDAANDA074520 | 1 | 1 |
| Chartwell Governmental & Specialty RX, LLC. | solution | ANDAANDA075039 | 1 | 0 |
| Upsher-Smith Laboratories, Inc. | tablet | ANDAANDA074625 | 1 | 0 |
| VerityRx | tablet | ANDAANDA209823 | 1 | 0 |
Bulk ingredient listings
- Aurobindo Pharma LimitedIndia · 1 NDC
- HARMAN FINOCHEM LIMITEDIndia · 1 NDC
- MEDISCA Inc.United States · 1 NDC
- PCASFrance · 1 NDC
- Piramal Healthcare (Canada) LimitedIndia · 1 NDC
- Professional Compounding Centers of America dba PCCAUnited States · 1 NDC
- THINQ Pharma-CRO LimitedIndia · 1 NDC
Orange Book patents
3 unexpired patents list oxybutynin chloride as the active ingredient, expiring between Nov 2029 and Mar 2031. Application holder: ABBVIE INC.
Enquiry
Common questions
- Who makes oxybutynin chloride?
- 36 companies list oxybutynin chloride as a human prescription drug in the openFDA NDC Directory, led by International Medication Systems, Ltd., Aphena Pharma Solutions - Tennessee, LLC, Bryant Ranch Prepack, PD-Rx Pharmaceuticals Inc., Rising Pharma Holdings, Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic oxybutynin chloride?
- 36 companies list oxybutynin chloride under an abbreviated new drug application (ANDA), the application type used for generics. Listing status is from the NDC Directory; it is not a statement of availability.
- Who supplies oxybutynin chloride active ingredient?
- 7 companies list oxybutynin chloride as a bulk ingredient, including Aurobindo Pharma Limited, HARMAN FINOCHEM LIMITED, MEDISCA Inc., PCAS.